Nicklas Westerholm
Chief Executive Officer bij EGETIS THERAPEUTICS AB
Vermogen: 123 465 $ op 31-03-2024
Profiel
Mr. Nicklas Westerholm is an Independent Director at Spago Nanomedical AB, a Chief Executive Officer at Egetis Therapeutics AB and a Chairman & Chief Executive Officer at Rare Thyroid Therapeutics International AB.
He is on the Board of Directors at Spago Nanomedical AB.
Mr. Westerholm was previously employed as a Vice President by AstraZeneca AB and an Investor Relations Contact by AstraZeneca PLC.
He received his undergraduate degree from the University of Stockholm and an undergraduate degree from Royal Institute of Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EGETIS THERAPEUTICS AB
0.07% | 31-12-2022 | 197 629 ( 0.07% ) | 123 465 $ | 31-03-2024 |
Actieve functies van Nicklas Westerholm
| Bedrijven | Functie | Begin |
|---|---|---|
| EGETIS THERAPEUTICS AB | Chief Executive Officer | 16-06-2017 |
| SPAGO NANOMEDICAL AB | Director/Board Member | 08-05-2019 |
Rare Thyroid Therapeutics International AB
 Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Chief Executive Officer | - |
Eerdere bekende functies van Nicklas Westerholm
| Bedrijven | Functie | Einde |
|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 01-06-2017 |
| ASTRAZENECA PLC | Investor Relations Contact | 08-09-2011 |
Opleiding van Nicklas Westerholm
| University of Stockholm | Undergraduate Degree |
| Royal Institute of Technology | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| EGETIS THERAPEUTICS AB | Health Technology |
| SPAGO NANOMEDICAL AB | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Rare Thyroid Therapeutics International AB
Rare Thyroid Therapeutics International AB BiotechnologyHealth Technology Rare Thyroid Therapeutics International AB provides thyroid therapeutics research services. The company is headquartered in Stockholm, Sweden. | Health Technology |
